What Is Multifocal Motor Neuropathy? Multifocal motor neuropathy (MMN) is a rare disease that causes slowly worsening muscle weakness, mainly in your hands, arms, and legs. It affects your body's ...
As of April 7 at 1:15:58 PM EDT. Market Open.
A former soldier received a diagnosis for a rare, incurable neurological condition after he was unable to give a thumbs up to a colleague. Clive Phillips, 50, from Birmingham but now living in Hope, ...
NEW YORK and WALTHAM, Mass., June 12, 2024 (GLOBE NEWSWIRE) -- Dianthus Therapeutics, Inc. (Nasdaq: DNTH), a clinical-stage biotechnology company dedicated to advancing the next generation of antibody ...
June 27, 2012 — Immune Globulin Infusion (Human), 10% (Gammagard Liquid, Baxter International, Inc), has been approved by the US Food and Drug Administration (FDA) as a treatment for multifocal motor ...
Simrat Randhawa, MD, Chief Medical Officer of Dianthus Therapeutics, expressed optimism about the potential benefits DNTH103 may offer to MMN patients. Dianthus Therapeutics is also initiating a Phase ...
Building a neuromuscular franchise with DNTH103 following the initiation of the Phase 2 MaGic trial in generalized Myasthenia Gravis (gMG) in 1Q’24 and planned initiation of a Phase 2 trial in Chronic ...
Find the latest Monarca Minerals Inc. (MMN.V) stock quote, history, news and other vital information to help you with your stock trading and investing.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results